Smith & Nephew Divesting ENT Line Within 12 Months, Keeping Rehab Unit

Smith & Nephew says it will retain its rehabilitation business, using it as a platform for building a product line to address the post-surgical orthopedic and active rehabilitation markets, as part of a corporate restructuring announced Nov. 2.

More from Archive

More from Medtech Insight